166 related articles for article (PubMed ID: 2169572)
1. Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
Metabolism; 1990 Sep; 39(9 Suppl 2):152-5. PubMed ID: 2169572
[TBL] [Abstract][Full Text] [Related]
2. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
3. [A new imaging procedure for detecting endocrine tumors].
Schäffer M; Fölsch UR
Z Gastroenterol; 1991 Apr; 29(4):173-4. PubMed ID: 1651031
[No Abstract] [Full Text] [Related]
4. Somatostatin-receptor imaging in the localization of endocrine tumors.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
N Engl J Med; 1990 Nov; 323(18):1246-9. PubMed ID: 2170840
[TBL] [Abstract][Full Text] [Related]
5. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor imaging with 123I-Tyr3-Octreotide.
Lamberts SW; Reubi JC; Bakker WH; Krenning EP
Z Gastroenterol; 1990 Sep; 28 Suppl 2():20-1. PubMed ID: 1980773
[TBL] [Abstract][Full Text] [Related]
7. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor scintigraphy in patients with pituitary adenoma.
Rieger A; Rainov NG; Elfrich C; Klaua M; Meyer H; Lautenschläger C; Burkert W; Mende T
Neurosurg Rev; 1997; 20(1):7-12. PubMed ID: 9085281
[TBL] [Abstract][Full Text] [Related]
9. Use of isotope-labeled somatostatin analogs for visualization of islet cell tumors.
van Eyck CH; Bruining HA; Reubi JC; Bakker WH; Oei HY; Krenning EP; Lamberts SW
World J Surg; 1993; 17(4):444-7. PubMed ID: 8395748
[TBL] [Abstract][Full Text] [Related]
10. Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide.
Nocaudie-Calzada M; Huglo D; Deveaux M; Carnaille B; Proye C; Marchandise X
J Nucl Med; 1994 Jan; 35(1):57-62. PubMed ID: 8271061
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor imaging in vivo localization of tumors with a radiolabeled somatostatin analog.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1079-82. PubMed ID: 1981011
[TBL] [Abstract][Full Text] [Related]
12. [Somatostatin receptor scintigraphy. Methodology, indications, results].
Eising EG; Bier D; Knust EJ; Reiners C
Radiologe; 1996 Jan; 36(1):81-8. PubMed ID: 8820376
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin-receptor imaging for the detection of tumors.
Patel YC
N Engl J Med; 1990 Nov; 323(18):1274-6. PubMed ID: 2170841
[No Abstract] [Full Text] [Related]
14. Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy.
Lamberts SW; Hofland LJ; de Herder WW; Kwekkeboom DJ; Reubi JC; Krenning EP
Front Neuroendocrinol; 1993 Jan; 14(1):27-55. PubMed ID: 8097480
[TBL] [Abstract][Full Text] [Related]
15. The clinical use of somatostatin analogues in the treatment of cancer.
Lamberts SW; Krenning EP; Klijn JG; Reubi JC
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):29-49. PubMed ID: 1975166
[TBL] [Abstract][Full Text] [Related]
16. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors.
Lamberts SW; Reubi JC; Krenning EP
Acta Oncol; 1993; 32(2):167-70. PubMed ID: 8391830
[TBL] [Abstract][Full Text] [Related]
17. [Significance of somatostatin receptors for diagnosis and therapy of endocrine pancreatic tumors].
Schusdziarra V
Z Gastroenterol; 1991 Jul; 29(7):363-4. PubMed ID: 1659049
[No Abstract] [Full Text] [Related]
18. In vivo somatostatin receptor imaging in the detection and treatment of gastrointestinal cancer.
Schubert ML
Gastroenterology; 1991 Apr; 100(4):1143-4. PubMed ID: 1848196
[No Abstract] [Full Text] [Related]
19. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
Faglia G; Bazzoni N; Spada A; Arosio M; Ambrosi B; Spinelli F; Sara R; Bonino C; Lunghi F
J Clin Endocrinol Metab; 1991 Oct; 73(4):850-6. PubMed ID: 1653785
[TBL] [Abstract][Full Text] [Related]
20. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
